Back to VA VANGUARD CAPITAL MANAGEMENT LLC
CTXR2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in CITIUS PHARMACEUTICALS INC
Yes. Vanguard Capital Management holds 197,364 shares of CTXR (Citius Pharmaceuticals), worth $119,405, as of its Q2 2026 13F filing. It increased the position by 29,626 shares (+17.7%) from Q1 2026. Vanguard Capital Management has held CTXR in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$119,405
Current Shares
197,364
Total Value Change
-$31,559
Total Shares Change
+29,626
Quarter-by-Quarter History
Other major holders of CTXR: VANGUARD GROUP INC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.